-
Antiviral API
- Arenavirus
- Cytomegalovirus (CMV)
- Dengue virus
- Endogenous Metabolite
- Enterovirus (EV)
- Epstein-Barr virus (EBV)
- Filovirus
- Flavivirus
- HCV Protease
- Hepatitis B Virus (HBV)
- Hepatitis C Virus (HCV)
- Herpes simplex Virus (HSV)
- HIF/HIF Prolyl-Hydroxylase
- HIV Integrase
- HIV Protease
- Human immunodeficiency Virus (HIV)
- Human papillomavirus (HPV)
- Influenza Virus
- Nipah virus
- Orthopoxvirus
- Others
- Rabies virus (RABV)
- Respiratory syncytial Virus (RSV)
- Reverse Transcriptases (RTs)
- SARS-CoV
- Tobacco mosaic virus (TMV)
- Vesicular stomatitis virus (VSV)
- Virus Protease
- West Nile virus
- Antiviral intermediates
Hydroxychloroquine-[d4] Sulfate
Category | SARS-CoV |
CAS | 1216432-56-2 |
Description | Hydroxychloroquine-[d4] Sulfate is an isotope labelled compound of Hydroxychloroquine Sulfate, an antimalarial, antirheumatic and lupus erythematosus suppressant. It is a COVID-19-related research product. |
Product Information
Synonyms | 2-[[4-[(7-Chloro-4-quinolinyl)amino]pentyl]ethylamino-d4]ethanol Sulfate; 7-Chloro-4-[4-[ethyl-d4(2-hydroxyethyl)amino]-1-methylbutylamino]-quinoline Sulfate; Ercoquin-d4; Plaquenil-d4 Sulfate; Quensyl-d4 |
IUPAC Name | 2-[[4-[(7-chloroquinolin-4-yl)amino]-1,1,2,2-tetradeuteriopentyl]-ethylamino]ethanol;sulfuric acid |
Molecular Weight | 437.97 |
Molecular Formula | C18H24D4ClN3O5S |
Canonical SMILES | CCN(CCCC(C)NC1=C2C=CC(=CC2=NC=C1)Cl)CCO.OS(=O)(=O)O |
InChI | InChI=1S/C18H26ClN3O.H2O4S/c1-3-22(11-12-23)10-4-5-14(2)21-17-8-9-20-18-13-15(19)6-7-16(17)18;1-5(2,3)4/h6-9,13-14,23H,3-5,10-12H2,1-2H3,(H,20,21);(H2,1,2,3,4)/i4D2,10D2; |
InChIKey | JCBIVZZPXRZKTI-LINVOLBQSA-N |
Melting Point | >140°C (dec.) |
Purity | 95% by CP; 95% atom D |
Solubility | Slightly soluble in Water, Methanol |
Appearance | White to Pale Yellow Solid |
Storage | Store at-20°C |
In Vitro | Stable heavy isotopes of hydrogen, carbon, and other elements have been incorporated into drug molecules, largely as tracers for quantitation during the drug development process. Deuteration has gained attention because of its potential to affect the pharmacokinetic and Metabolic profiles of drugs. |
PSA | 131.37000 |
Target | Parasite; Toll-like Receptor (TLR); SARS-CoV; Autophagy |